Insulin aspart, recombinant Subcutaneous and Raltegravir Chewable Tablets
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Raltegravir Chewable Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: raltegravir
Brand name: Isentress, Isentress HD
Synonyms: Raltegravir
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Raltegravir Potassium
- Insulin aspart, recombinant Subcutaneous-Raltegravir Powder for Oral Suspension
- Insulin aspart, recombinant Subcutaneous-Raltegravir Tablets
- Insulin aspart, recombinant Subcutaneous-Ramelteon
- Insulin aspart, recombinant Subcutaneous-Ramelteon Tablets
- Insulin aspart, recombinant Subcutaneous-Ramipril
- Raltegravir Chewable Tablets-Insulin degludec
- Raltegravir Chewable Tablets-Insulin Degludec (U-100) Prefilled Pens
- Raltegravir Chewable Tablets-Insulin Degludec (U-100) Vials
- Raltegravir Chewable Tablets-Insulin Degludec (U-200) Prefilled Pens
- Raltegravir Chewable Tablets-Insulin degludec and liraglutide
- Raltegravir Chewable Tablets-Insulin degludec and liraglutide Subcutaneous